Douglas Nixon - Publications

Affiliations: 
Biomedical Sciences University of California, San Francisco, San Francisco, CA 
Area:
Microbiology Biology, Immunology

140 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Dopkins N, Fei T, Michael S, Liotta N, Guo K, Mickens KL, Barrett BS, Bendall ML, Dillon SM, Wilson CC, Santiago ML, Nixon DF. Endogenous retroelement expression in the gut microenvironment of people living with HIV-1. Ebiomedicine. 103: 105133. PMID 38677181 DOI: 10.1016/j.ebiom.2024.105133  0.364
2024 Crater JM, Dunn D, Nixon DF, O'Brien RLF. HIV-1 Mediated Cortical Actin Disruption Mirrors ARP2/3 Defects Found in Primary T Cell Immunodeficiencies. Biorxiv : the Preprint Server For Biology. PMID 38405733 DOI: 10.1101/2023.07.27.550856  0.405
2023 Singh M, Leddy SM, Iñiguez LP, Bendall ML, Nixon DF, Feschotte C. Transposable elements may enhance antiviral resistance in HIV-1 elite controllers. Biorxiv : the Preprint Server For Biology. PMID 38168352 DOI: 10.1101/2023.12.11.571123  0.415
2023 Lyons DE, Kumar P, Roan NR, Defechereux PA, Feschotte C, Lange UC, Murthy N, Sameshima P, Verdin E, Ake JA, Parsons MS, Nath A, Gianella S, Smith DM, Kallas EG, ... ... Nixon DF, et al. HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing. Viruses. 15. PMID 38005849 DOI: 10.3390/v15112171  0.385
2023 Crater JM, Dunn DC, Nixon DF, Furler O'Brien RL. A History and Atlas of the Human CD4 T Helper Cell. Biomedicines. 11. PMID 37892982 DOI: 10.3390/biomedicines11102608  0.303
2022 Dopkins N, Nixon DF. Two-step recognition of HIV-1 DNA in the cytosol. Trends in Microbiology. PMID 36153261 DOI: 10.1016/j.tim.2022.09.007  0.317
2022 Duarte RRR, Pain O, Furler RL, Nixon DF, Powell TR. Transcriptome-wide association study of HIV-1 acquisition identifies as a susceptibility gene. Iscience. 25: 104854. PMID 36034232 DOI: 10.1016/j.isci.2022.104854  0.348
2022 Curty G, Iniguez LP, Soares MA, Nixon DF, de Mulder Rougvie M. Off-Target Effect of Activation of NF-κB by HIV Latency Reversal Agents on Transposable Elements Expression. Viruses. 14. PMID 35891551 DOI: 10.3390/v14071571  0.321
2021 Furler RL, Nixon DF. HIV-1 Exploits Transitions Between CD4 T Cell Migration and Activation. Aids Research and Human Retroviruses. PMID 34714116 DOI: 10.1089/AID.2021.0137  0.374
2021 Kumari N, Nouraie SM, Ahmad A, Lassiter H, Khan JI, Diaz SF, Afangbedji N, Wang S, Houston PE, Ammosova T, de Mulder Rougvie M, Rana S, Nixon D, Anastos K, Lazar J, et al. Restriction of HIV-1 Infection in Sickle Cell Trait. Blood Advances. PMID 34496009 DOI: 10.1182/bloodadvances.2021004247  0.414
2021 Premeaux TA, Mediouni S, Leda A, Furler RL, Valente ST, Fine HA, Nixon DF, Ndhlovu LC. Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research. Mbio. e0068021. PMID 34253056 DOI: 10.1128/mBio.00680-21  0.303
2021 Bortlik M, Copertino DC, Brailey PM, Beckerle GA, Ormsby CE, Rosenberg MG, Wiznia AA, Raposo RAS, Nixon DF, de Mulder Rougvie M. Restriction Factor Expression in Vertically Infected Children Living With HIV-1. The Pediatric Infectious Disease Journal. 40: 144-146. PMID 33395209 DOI: 10.1097/INF.0000000000002924  0.363
2020 Wozniak RJ, Cerqueira NB, Dantas MCS, Mahafe B, Barros DAC, Alves de Medeiros E, Soares de Oliveira AC, Sabino T, Roggenbuck A, Avelino-Silva VI, Johnston CD, Marston JL, Bidegain SC, Magnus M, Kallas EG, ... Nixon DF, et al. Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil. Bmj Open. 10: e040092. PMID 33177141 DOI: 10.1136/bmjopen-2020-040092  0.36
2020 Powell AB, Ren Y, Korom M, Saunders D, Hanley PJ, Goldstein H, Nixon DF, Bollard CM, Lynch RM, Jones RB, Cruz CRY. Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV. Molecular Therapy. Methods & Clinical Development. 19: 78-88. PMID 33005704 DOI: 10.1016/J.Omtm.2020.08.015  0.451
2020 Nixon DF. Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'. Journal of Medical Virology. PMID 32242946 DOI: 10.1002/jmv.25821  0.352
2020 Powell TR, Duarte RRR, Hotopf M, Hatch SL, de Mulder Rougvie M, Breen GD, Lewis CM, Nixon DF. The behavioral, cellular and immune mediators of HIV-1 acquisition: New insights from population genetics. Scientific Reports. 10: 3304. PMID 32094379 DOI: 10.1038/s41598-020-59256-0  0.389
2020 Pasayan MKU, Alabi AA, Nixon DF. Conditional economic incentives to improve HIV prevention. The Lancet. Hiv. 7: e85. PMID 32027854 DOI: 10.1016/S2352-3018(19)30431-X  0.32
2020 Patel S, Hanajiri R, Grant M, Saunders D, Van Pelt S, Keller M, Hanley PJ, Simon G, Nixon DF, Hardy D, Jones RB, Bollard CM. HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform. Molecular Therapy. Methods & Clinical Development. 16: 11-20. PMID 31720305 DOI: 10.1016/j.omtm.2019.10.001  0.46
2020 Powell A, Ren Y, Korom M, Saunders D, Hanley P, Goldstein H, Nixon D, Bollard C, Lynch R, Jones R, Cruz C. Engineered antigen-specific T cells secreting broadly neutralizing antibodies: combining innate and adaptive immune response against HIV Cytotherapy. 22: S123-S124. DOI: 10.1016/J.Jcyt.2020.03.232  0.512
2019 Furler RL, Newcombe KL, Del Rio P, Reyes-Teran G, Uittenbogaart CH, Nixon DF. Histoarchitectural Deterioration of Lymphoid Tissues in HIV-1 Infection and in Aging. Aids Research and Human Retroviruses. PMID 31474115 DOI: 10.1089/Aid.2019.0156  0.365
2019 Furler RL, Ali A, Yang OO, Nixon DF. Nef-induced differential gene expression in primary CD4+ T cells following infection with HIV-1 isolates. Virus Genes. PMID 31093843 DOI: 10.1007/S11262-019-01670-2  0.357
2019 Marston JL, Marín-Hernández D, Nixon DF. Addressing the HIV crisis in the Philippines. The Lancet. Public Health. 4: e126. PMID 30851867 DOI: 10.1016/S2468-2667(19)30024-6  0.371
2019 Furler RL, Nixon DF. The Intimate Relationship Between CD4+ T Cell Morphology and HIV-1 Infection. Aids Research and Human Retroviruses. PMID 30835143 DOI: 10.1089/Aid.2019.0011  0.403
2018 Paquin-Proulx D, Greenspun BC, Kitchen SM, Saraiva Raposo RA, Nixon DF, Grayfer L. Human interleukin-34-derived macrophages have increased resistant to HIV-1 infection. Cytokine. 111: 272-277. PMID 30241016 DOI: 10.1016/j.cyto.2018.09.006  0.385
2018 Osuna CE, Lim SY, Kublin JL, Apps R, Chen E, Mota TM, Huang SH, Ren Y, Bachtel ND, Tsibris AM, Ackerman ME, Jones RB, Nixon DF, Whitney JB. Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature. 561: E20-E28. PMID 30232424 DOI: 10.1038/S41586-018-0495-2  0.364
2018 Bachtel ND, Beckerle GA, Mota T, Rougvie MM, Raposo RA, Jones RB, Nixon DF, Apps R. Expression of host restriction factors by memory CD4+ T cells differs between healthy donors and HIV-1 infected individuals with effective ART. Aids Research and Human Retroviruses. PMID 30198299 DOI: 10.1089/AID.2018.0162  0.411
2018 Paquin-Proulx D, Costa PR, Terrassani Silveira CG, Marmorato MP, Cerqueira NB, Sutton MS, O'Connor SL, Carvalho KI, Nixon DF, Kallas EG. Latent Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells. Frontiers in Immunology. 9: 1394. PMID 29971068 DOI: 10.3389/Fimmu.2018.01394  0.336
2018 Macedo AB, Resop RS, Martins LJ, Szaniawski MA, Sorensen ES, Spivak AM, Nixon DF, Jones RB, Planelles V, Bosque A. Influence of biological sex, age and HIV status in an in vitro primary cell model of HIV latency using a CXCR4 tropic virus. Aids Research and Human Retroviruses. PMID 29926732 DOI: 10.1089/Aid.2018.0098  0.424
2018 Webb GM, Li S, Mwakalundwa G, Folkvord JM, Greene JM, Reed JS, Stanton JJ, Legasse AW, Hobbs T, Martin LD, Park BS, Whitney JB, Jeng EK, Wong HC, Nixon DF, et al. The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles. Blood Advances. 2: 76-84. PMID 29365313 DOI: 10.1182/Bloodadvances.2017012971  0.41
2018 Huang SH, Ren Y, Thomas AS, Chan D, Mueller S, Ward AR, Patel S, Bollard CM, Cruz CR, Karandish S, Truong R, Macedo AB, Bosque A, Kovacs C, Benko E, ... ... Nixon DF, et al. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. The Journal of Clinical Investigation. PMID 29355843 DOI: 10.1172/Jci97555  0.366
2018 Kumari N, de Mulder M, Khan J, Ahmad A, Wang S, Lassiter H, Smith N, Afangbedji NKA, Ivanov A, Shah M, Diaz S, Rana S, Nixon D, Nekhai S. Restriction of HIV-1 Infection in Sickle Cell Disease and Trait Blood. 132: 2337-2337. DOI: 10.1182/Blood-2018-99-117029  0.484
2018 Patel S, Huang J, Saunders D, Hoq F, Roesch L, Hanley P, Keller MD, Simon G, Nixon D, Jones B, Bollard C. HIV-specific T cells can be generated against conserved non-escaped HIV epitopes for use in a phase I clinical trial: Pre-clinical validations and implications for a cure strategy for HIV Cytotherapy. 20. DOI: 10.1016/J.Jcyt.2018.02.015  0.465
2018 Apps R, Bachtel N, Umviligihozo G, Pickering S, Mota T, Liang H, Prete GD, Chatterjee P, Lee G, Thomas R, Brockman M, Neil S, Carrington M, Bwana B, Bangsberg D, ... ... Nixon D, et al. OR21 HLA-C downregulation by HIV adapts to host HLA genotype Human Immunology. 79: 28. DOI: 10.1016/J.Humimm.2018.07.026  0.387
2017 de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF, Michaud HA. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers. Retrovirology. 14: 41. PMID 28830571 DOI: 10.1186/s12977-017-0365-2  0.312
2017 Wu JJ, Gilbert KE, Batech M, Manalo IF, Towner WJ, Raposo RA, Nixon DF, Liao W. Examining HIV Viral Load in a Matched Cohort of HIV Positive Individuals With and Without Psoriasis. Journal of Drugs in Dermatology : Jdd. 16: 372-377. PMID 28403272  0.352
2017 Geddes VE, José DP, Leal FE, Nixon DF, Tanuri A, Aguiar RS. HTLV-1 Tax activates HIV-1 transcription in latency models. Virology. 504: 45-51. PMID 28152383 DOI: 10.1016/j.virol.2017.01.014  0.414
2017 Raposo RA, de Mulder Rougvie M, Paquin-Proulx D, Brailey PM, Cabido VD, Zdinak PM, Thomas AS, Huang SH, Beckerle GA, Jones RB, Nixon DF. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. Jci Insight. 2: e85811. PMID 28097226 DOI: 10.1172/jci.insight.85811  0.4
2017 Kumari N, Mulder Md, Afangbedji NKA, Wang S, Diaz S, Nixon D, Nekhai S. Hemin and Iron Modulated Intrinsic Cellular Factors Regulate HIV-1 Replication in Sickle Cell Disease Blood. 130: 3492-3492. DOI: 10.1182/Blood.V130.Suppl_1.3492.3492  0.397
2016 Nititham J, Gupta R, Zeng X, Hartogensis W, Nixon DF, Deeks SG, Hecht FM, Liao W. Psoriasis risk SNPs and their association with HIV-1 control. Human Immunology. PMID 27810495 DOI: 10.1016/J.Humimm.2016.10.018  0.359
2016 Paquin-Proulx D, Gibbs A, Bächle SM, Checa A, Introini A, Leeansyah E, Wheelock CE, Nixon DF, Broliden K, Tjernlund A, Moll M, Sandberg JK. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. Journal of Immunology (Baltimore, Md. : 1950). PMID 27481843 DOI: 10.4049/Jimmunol.1600556  0.434
2016 Willberg CB, Garrison KE, Jones RB, Meiklejohn DA, Spotts G, Liegler TJ, Ostrowski MA, Karlsson AC, Hecht FM, Nixon DF. Correction: Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+ T Cells Recognize Vestigial CTL Epitopes. Plos One. 11: e0160293. PMID 27454121 DOI: 10.1371/journal.pone.0160293  0.359
2016 Patel S, Jones RB, Bollard CM, Nixon DF. T-cell therapies for HIV: Preclinical successes and current clinical strategies. Cytotherapy. PMID 27265874 DOI: 10.1016/j.jcyt.2016.04.007  0.428
2016 Kuebler PJ, Shaw BI, Leadabrand KS, Mehrotra ML, Grant RM, Kallás EG, Nixon DF. Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial. Journal of Acquired Immune Deficiency Syndromes (1999). 72: 184-8. PMID 26674373 DOI: 10.1097/QAI.0000000000000923  0.417
2016 Kuebler P, Mehrotra M, McConnell J, Holditch S, Shaw B, Tarosso L, Leadabrand K, Milush J, York V, Raposo RAS, Cheng R, Eriksson E, McMahan V, Glidden D, Shiboski S, ... ... Nixon D, et al. D-106 Cellular immune correlates analysis of an HIV-1 pre- exposure prophylaxis trial Journal of Acquired Immune Deficiency Syndromes. 71: 54. DOI: 10.1097/01.Qai.0000479554.52108.29  0.408
2015 Kuebler PJ, Mehrotra ML, Shaw BI, Leadabrand KS, Milush JM, York VA, Defechereux P, Grant RM, Kallás EG, Nixon DF. Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation. The Journal of Infectious Diseases. PMID 26310308 DOI: 10.1093/infdis/jiv425  0.432
2015 Kuebler PJ, Mehrotra ML, McConnell JJ, Holditch SJ, Shaw BI, Tarosso LF, Leadabrand KS, Milush JM, York VA, Raposo RA, Cheng RG, Eriksson EM, McMahan V, Glidden DV, Shiboski S, ... ... Nixon DF, et al. Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial. Proceedings of the National Academy of Sciences of the United States of America. 112: 8379-84. PMID 26100867 DOI: 10.1073/pnas.1501443112  0.428
2014 Eriksson EM, Liegler T, Keh CE, Karlsson AC, Holditch SJ, Pilcher CD, Loeb L, Nixon DF, Hecht FM. Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences. Plos One. 10: e0120787. PMID 25919393 DOI: 10.1371/journal.pone.0120787  0.356
2014 Ribeiro SP, Milush JM, Cunha-Neto E, Kallas EG, Kalil J, Somsouk M, Hunt PW, Deeks SG, Nixon DF, SenGupta D. The CD8⁺ memory stem T cell (T(SCM)) subset is associated with improved prognosis in chronic HIV-1 infection. Journal of Virology. 88: 13836-44. PMID 25253339 DOI: 10.1128/JVI.01948-14  0.343
2014 Raposo RA, Abdel-Mohsen M, Deng X, Hecht FM, Pilcher CD, Pillai SK, Nixon DF. Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo. Journal of Virology. 88: 11624-9. PMID 25031350 DOI: 10.1128/Jvi.01771-14  0.329
2014 Michaud HA, SenGupta D, de Mulder M, Deeks SG, Martin JN, Kobie JJ, Sacha JB, Nixon DF. Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells. Journal of Immunology (Baltimore, Md. : 1950). 193: 1544-8. PMID 25024383 DOI: 10.4049/Jimmunol.1302108  0.438
2014 Sheppard NC, Jones RB, Burwitz BJ, Nimityongskul FA, Newman LP, Buechler MB, Reed JS, Piaskowski SM, Weisgrau KL, Castrovinci PA, Wilson NA, Ostrowski MA, Park B, Nixon DF, Rakasz EG, et al. Vaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replication. Plos One. 9: e92012. PMID 24651676 DOI: 10.1371/journal.pone.0092012  0.378
2014 Michaud HA, de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection. Retrovirology. 11: 10. PMID 24472118 DOI: 10.1186/1742-4690-11-10  0.324
2014 Emu B, Moretto WJ, Hoh R, Krone M, Martin JN, Nixon DF, Deeks SG, McCune JM. Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease. Plos One. 9: e85613. PMID 24465619 DOI: 10.1371/journal.pone.0085613  0.373
2013 Milush JM, López-Vergès S, York VA, Deeks SG, Martin JN, Hecht FM, Lanier LL, Nixon DF. CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection. Retrovirology. 10: 158. PMID 24351015 DOI: 10.1186/1742-4690-10-158  0.383
2013 Abdel-Mohsen M, Raposo RA, Deng X, Li M, Liegler T, Sinclair E, Salama MS, Ghanem Hel-D, Hoh R, Wong JK, David M, Nixon DF, Deeks SG, Pillai SK. Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology. 10: 106. PMID 24131498 DOI: 10.1186/1742-4690-10-106  0.404
2013 Jones RB, Song H, Xu Y, Garrison KE, Buzdin AA, Anwar N, Hunter DV, Mujib S, Mihajlovic V, Martin E, Lee E, Kuciak M, Raposo RA, Bozorgzad A, Meiklejohn DA, ... ... Nixon DF, et al. LINE-1 retrotransposable element DNA accumulates in HIV-1-infected cells. Journal of Virology. 87: 13307-20. PMID 24089548 DOI: 10.1128/Jvi.02257-13  0.365
2013 Raposo RA, Abdel-Mohsen M, Bilska M, Montefiori DC, Nixon DF, Pillai SK. Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells. Journal of Virology. 87: 11924-9. PMID 23966394 DOI: 10.1128/Jvi.02128-13  0.392
2013 Raposo RA, Abdel-Mohsen M, Holditch SJ, Kuebler PJ, Cheng RG, Eriksson EM, Liao W, Pillai SK, Nixon DF. Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals. Journal of Leukocyte Biology. 94: 1051-9. PMID 23929683 DOI: 10.1189/Jlb.0313150  0.389
2013 Champiat S, Garrison KE, Raposo RA, Burwitz BJ, Reed J, Tandon R, York VA, Newman LP, Nimityongskul FA, Wilson NA, Almeida RR, Martin JN, Deeks SG, Rosenberg MG, Wiznia AA, ... ... Nixon DF, et al. T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques. Journal of Virology. 87: 6073-80. PMID 23536679 DOI: 10.1128/Jvi.00579-12  0.36
2013 Perez CL, Milush JM, Buggert M, Eriksson EM, Larsen MV, Liegler T, Hartogensis W, Bacchetti P, Lund O, Hecht FM, Nixon DF, Karlsson AC. Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion. Aids Research and Human Retroviruses. 29: 602-12. PMID 23140171 DOI: 10.1089/Aid.2012.0171  0.45
2012 Eriksson EM, Keh CE, Deeks SG, Martin JN, Hecht FM, Nixon DF. Differential Expression of CD96 Surface Molecule Represents CD8+ T Cells with Dissimilar Effector Function during HIV-1 Infection Plos One. 7. PMID 23272144 DOI: 10.1371/journal.pone.0051696  0.34
2012 Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, Hunter DV, Martin E, John VM, Zhan W, Faruk NF, Gyenes G, Sheppard NC, Priumboom-Brees IM, Goodwin DA, Chen L, ... ... Nixon DF, et al. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. The Journal of Clinical Investigation. 122: 4473-89. PMID 23143309 DOI: 10.1172/Jci64560  0.449
2012 Tandon R, Giret MT, Sengupta D, York VA, Wiznia AA, Rosenberg MG, Kallas EG, Ndhlovu LC, Nixon DF. Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children. Plos One. 7: e45733. PMID 23029209 DOI: 10.1371/journal.pone.0045733  0.415
2012 Ormsby CE, Sengupta D, Tandon R, Deeks SG, Martin JN, Jones RB, Ostrowski MA, Garrison KE, Vázquez-Pérez JA, Reyes-Terán G, Nixon DF. Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection. Plos One. 7: e41021. PMID 22879884 DOI: 10.1371/Journal.Pone.0041021  0.418
2012 Champiat S, Raposo RA, Maness NJ, Lehman JL, Purtell SE, Hasenkrug AM, Miller JC, Dean H, Koff WC, Hong MA, Martin JN, Deeks SG, Spotts GE, Pilcher CD, Hecht FM, ... ... Nixon DF, et al. Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection. Plos One. 7: e39311. PMID 22768072 DOI: 10.1371/Journal.Pone.0039311  0.378
2012 Sacha JB, Kim IJ, Chen L, Ullah JH, Goodwin DA, Simmons HA, Schenkman DI, von Pelchrzim F, Gifford RJ, Nimityongskul FA, Newman LP, Wildeboer S, Lappin PB, Hammond D, Castrovinci P, ... ... Nixon DF, et al. Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic. Journal of Immunology (Baltimore, Md. : 1950). 189: 1467-79. PMID 22745376 DOI: 10.4049/Jimmunol.1200079  0.335
2012 Chen H, Hayashi G, Lai OY, Dilthey A, Kuebler PJ, Wong TV, Martin MP, Fernandez Vina MA, McVean G, Wabl M, Leslie KS, Maurer T, Martin JN, Deeks SG, Carrington M, ... ... Nixon DF, et al. Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease. Plos Genetics. 8: e1002514. PMID 22577363 DOI: 10.1371/Journal.Pgen.1002514  0.341
2012 Sandberg JK, Andersson SK, Bächle SM, Nixon DF, Moll M. HIV-1 Vpu interference with innate cell-mediated immune mechanisms. Current Hiv Research. 10: 327-33. PMID 22524181  0.391
2012 Carvalho KI, Bruno FR, Snyder-Cappione JE, Maeda SM, Tomimori J, Xavier MB, Haslett PA, Nixon DF, Kallas EG. Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients. Immunology. 136: 96-102. PMID 22269018 DOI: 10.1111/j.1365-2567.2012.03563.x  0.389
2012 Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF. Association of differentiation state of CD4+ T cells and disease progression in HIV-1 perinatally infected children Plos One. 7. PMID 22247768 DOI: 10.1371/journal.pone.0029154  0.356
2012 Eriksson EM, Milush JM, Ho EL, Batista MD, Holditch SJ, Keh CE, Norris PJ, Keating SM, Deeks SG, Hunt PW, Martin JN, Rosenberg MG, Hecht FM, Nixon DF. Expansion of CD8 + T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity Blood. 119: 745-755. PMID 22134167 DOI: 10.1182/blood-2010-12-324848  0.366
2011 Holditch SJ, Eriksson EM, Tarosso LF, Kuebler PJ, Kallas EG, Nielsen EK, Wiznia AA, Rosenberg MG, Nixon DF. Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants. Frontiers in Immunology. 2: 94. PMID 22566883 DOI: 10.3389/fimmu.2011.00094  0.4
2011 Tandon R, SenGupta D, Ndhlovu LC, Vieira RG, Jones RB, York VA, Vieira VA, Sharp ER, Wiznia AA, Ostrowski MA, Rosenberg MG, Nixon DF. Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects. Journal of Virology. 85: 11526-31. PMID 21880743 DOI: 10.1128/Jvi.05418-11  0.44
2011 Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF. Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents Plos One. 6. PMID 21818255 DOI: 10.1371/journal.pone.0021135  0.416
2011 Ndhlovu LC, Leal FE, Hasenkrug AM, Jha AR, Carvalho KI, Eccles-James IG, Bruno FR, Vieira RG, York VA, Chew GM, Jones RB, Tanaka Y, Neto WK, Sanabani SS, Ostrowski MA, ... ... Nixon DF, et al. HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications. Plos Neglected Tropical Diseases. 5: e1030. PMID 21541358 DOI: 10.1371/journal.pntd.0001030  0.317
2011 SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN, York VA, Spotts G, Reyes-Terán G, Ostrowski MA, Hecht FM, ... ... Nixon DF, et al. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. Journal of Virology. 85: 6977-85. PMID 21525339 DOI: 10.1128/Jvi.00179-11  0.47
2010 Streeck H, Nixon DF. T cell immunity in acute HIV-1 infection. The Journal of Infectious Diseases. S302-8. PMID 20846037 DOI: 10.1086/655652  0.388
2010 Ndhlovu LC, Sinclair E, Epling L, Tan QX, Ho T, Jha AR, Eccles-James I, Tincati C, Levy JA, Nixon DF, Hecht FM, Barbour JD. IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. Journal of Clinical Immunology. 30: 681-92. PMID 20571894 DOI: 10.1007/S10875-010-9432-3  0.349
2010 Willberg CB, Garrison KE, Jones RB, Meiklejohn DJ, Spotts G, Liegler TJ, Ostrowski MA, Karlsson AC, Hecht FM, Nixon DF. Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes. Plos One. 5: e10249. PMID 20422053 DOI: 10.1371/Journal.Pone.0010249  0.441
2010 Long BR, Erickson AE, Chapman JM, Barbour JD, Vu BA, Ho EL, Lanier LL, Sauer MM, Carvalho KI, Nixon DF, Kallas EG. Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2. Immunology. 129: 186-96. PMID 19824915 DOI: 10.1111/J.1365-2567.2009.03170.X  0.388
2009 Snyder-Cappione JE, Loo CP, Carvalho KI, Kuylenstierna C, Deeks SG, Hecht FM, Rosenberg MG, Sandberg JK, Kallas EG, Nixon DF. Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression Aids. 23: 1965-1970. PMID 19590406 DOI: 10.1097/QAD.0b013e32832b5134  0.417
2009 Garrison KE, Champiat S, York VA, Agrawal AT, Kallas EG, Martin JN, Hecht FM, Deeks SG, Nixon DF. Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses. Clinical and Vaccine Immunology : Cvi. 16: 1369-71. PMID 19571107 DOI: 10.1128/Cvi.00410-08  0.399
2009 Loo CP, Long BR, Hecht FM, Nixon DF, Michaëlsson J. HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens. Aids Research and Human Retroviruses. 25: 603-5. PMID 19500013 DOI: 10.1089/Aid.2008.0165  0.426
2009 Torheim EA, Ndhlovu LC, Pettersen FO, Larsen TL, Jha AR, Torgersen KM, Kvale D, Nixon DF, Taskén K, Aandahl EM. Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population. European Journal of Immunology. 39: 1280-7. PMID 19384871 DOI: 10.1002/eji.200839002  0.441
2009 Willberg CB, Nixon DF. Treatment interruption in chronic HIV-1 infection: does it deliver? Current Opinion in Hiv and Aids. 2: 26-30. PMID 19372862 DOI: 10.1097/COH.0b013e3280119307  0.306
2009 Cheng RG, Nixon DF. Herpes simplex virus and HIV-1: deciphering viral synergy. The Lancet. Infectious Diseases. 9: 74; author reply 74-. PMID 19179220 DOI: 10.1016/S1473-3099(09)70002-7  0.33
2009 Ndhlovu L, Sinclair E, Epling L, Tan QX, Ho T, Jha AR, Levy JA, Nixon DF, Barbour JD, Hecht FM. P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses Retrovirology. 6: P239. DOI: 10.1186/1742-4690-6-S3-P239  0.414
2008 Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, Wong JC, Satkunarajah M, Schweneker M, Chapman JM, Gyenes G, Vali B, Hyrcza MD, Yue FY, Kovacs C, ... ... Nixon DF, et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. The Journal of Experimental Medicine. 205: 2763-79. PMID 19001139 DOI: 10.1084/Jem.20081398  0.459
2008 Willberg CB, McConnell JJ, Eriksson EM, Bragg LA, York VA, Liegler TJ, Hecht FM, Grant RM, Nixon DF. Immunity to HIV-1 is influenced by continued natural exposure to exogenous virus. Plos Pathogens. 4: e1000185. PMID 18949024 DOI: 10.1371/journal.ppat.1000185  0.423
2008 Ndhlovu LC, Chapman JM, Jha AR, Snyder-Cappione JE, Pagán M, Leal FE, Boland BS, Norris PJ, Rosenberg MG, Nixon DF. Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection. Aids (London, England). 22: 990-2. PMID 18453860 DOI: 10.1097/QAD.0b013e3282ff884e  0.392
2008 Pérez CL, Larsen MV, Gustafsson R, Norström MM, Atlas A, Nixon DF, Nielsen M, Lund O, Karlsson AC. Broadly immunogenic HLA class I supertype-restricted elite CTL epitopes recognized in a diverse population infected with different HIV-1 subtypes. Journal of Immunology (Baltimore, Md. : 1950). 180: 5092-100. PMID 18354235  0.343
2008 Long BR, Ndhlovu LC, Oksenberg JR, Lanier LL, Hecht FM, Nixon DF, Barbour JD. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. Journal of Virology. 82: 4785-92. PMID 18305035 DOI: 10.1128/Jvi.02449-07  0.392
2008 Lee AW, Sharp ER, O'Mahony A, Rosenberg MG, Israelski DM, Nolan GP, Nixon DF. Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection. Journal of Virology. 82: 3702-12. PMID 18216116 DOI: 10.1128/Jvi.01582-07  0.389
2008 Michaëlsson J, Long BR, Loo CP, Lanier LL, Spotts G, Hecht FM, Nixon DF. Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2. The Journal of Infectious Diseases. 197: 117-25. PMID 18171294 DOI: 10.1086/524141  0.371
2007 Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, Chapman JM, Erickson AL, Agrawal A, Spotts G, Hecht FM, Rakoff-Nahoum S, Lenz J, Ostrowski MA, Nixon DF. T cell responses to human endogenous retroviruses in HIV-1 infection. Plos Pathogens. 3: e165. PMID 17997601 DOI: 10.1371/Journal.Ppat.0030165  0.48
2007 Ndhlovu LC, Loo CP, Spotts G, Nixon DF, Hecht FM. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection. Journal of Leukocyte Biology. 83: 254-62. PMID 17982112 DOI: 10.1189/jlb.0507281  0.372
2007 Barbour JD, Sauer MM, Sharp ER, Garrison KE, Long BR, Tomiyama H, Bassichetto KC, Oliveira SM, Abbate MC, Nixon DF, Kallas EG. HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts. Plos One. 2: e1080. PMID 17957262 DOI: 10.1371/Journal.Pone.0001080  0.433
2007 Ballan WM, Vu BA, Long BR, Loo CP, Michaëlsson J, Barbour JD, Lanier LL, Wiznia AA, Abadi J, Fennelly GJ, Rosenberg MG, Nixon DF. Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity. Journal of Immunology (Baltimore, Md. : 1950). 179: 3362-70. PMID 17709553 DOI: 10.4049/Jimmunol.179.5.3362  0.369
2007 Northfield JW, Loo CP, Barbour JD, Spotts G, Hecht FM, Klenerman P, Nixon DF, Michaëlsson J. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. Journal of Virology. 81: 5759-65. PMID 17376902 DOI: 10.1128/JVI.00045-07  0.436
2007 Karlsson AC, Iversen AK, Chapman JM, de Oliviera T, Spotts G, McMichael AJ, Davenport MP, Hecht FM, Nixon DF. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. Plos One. 2: e225. PMID 17311088 DOI: 10.1371/journal.pone.0000225  0.375
2007 Northfield JW, Loo C, Michaelsson J, Nixon D, Klenerman P. It's not what you've got it's what you do with it: Identifying the components of a Better Immune Response to HIV Journal of Infection. 54. DOI: 10.1016/J.Jinf.2006.10.023  0.408
2006 Metzner KJ, Binley JM, Gettie A, Marx P, Nixon DF, Connor RI. Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques. Retrovirology. 3: 97. PMID 17184540 DOI: 10.1186/1742-4690-3-97  0.323
2006 Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, Miyamoto M, Diaz RS, Santos AMN, Succi RCM, Abadi J, Rosenberg MG, de Moraes-Pinto MI, Kallas EG. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal Plos One. 1. PMID 17183635 DOI: 10.1371/journal.pone.0000102  0.443
2006 Nomura LE, Emu B, Hoh R, Haaland P, Deeks SG, Martin JN, McCune JM, Nixon DF, Maecker HT. IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells. Aids Research and Therapy. 3: 18. PMID 16859558 DOI: 10.1186/1742-6405-3-18  0.434
2006 Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM. Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42: 700-8. PMID 16447118 DOI: 10.1086/500215  0.395
2006 Papasavvas E, Kostman JR, Thiel B, Pistilli M, Mackiewicz A, Foulkes A, Gross R, Jordan KA, Nixon DF, Grant R, Poulin JF, McCune JM, Mounzer K, Montaner LJ. HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption. Journal of Clinical Immunology. 26: 40-54. PMID 16418802 DOI: 10.1007/S10875-006-7518-8  0.432
2006 Jordan KA, Furlan SN, Gonzalez VD, Karlsson AC, Quigley MF, Deeks SG, Rosenberg MG, Nixon DF, Sandberg JK. CD8 T cell effector maturation in HIV-1-infected children. Virology. 347: 117-26. PMID 16406047 DOI: 10.1016/j.virol.2005.12.002  0.369
2006 Moll M, Snyder-Cappione J, Spotts G, Hecht FM, Sandberg JK, Nixon DF. Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood. 107: 3081-3. PMID 16368878 DOI: 10.1182/blood-2005-09-3636  0.375
2005 Metzner KJ, Moretto WJ, Donahoe SM, Jin X, Gettie A, Montefiori DC, Marx PA, Binley JM, Nixon DF, Connor RI. Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus. The Journal of General Virology. 86: 3375-84. PMID 16298985 DOI: 10.1099/Vir.0.81206-0  0.366
2005 Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R, Martin JN, Nixon DF, McCune JM, Deeks SG. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment Journal of Virology. 79: 14169-14178. PMID 16254352 DOI: 10.1128/JVI.79.22.14169-14178.2005  0.456
2005 Sharp ER, Barbour JD, Karlsson RK, Jordan KA, Sandberg JK, Wiznia A, Rosenberg MG, Nixon DF. Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1. The Journal of Infectious Diseases. 192: 1772-80. PMID 16235176 DOI: 10.1086/462423  0.439
2005 Legrand FA, Abadi J, Jordan KA, Davenport MP, Deeks SG, Fennelly GJ, Wiznia AA, Nixon DF, Rosenberg MG. Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients. Aids (London, England). 19: 1575-85. PMID 16184026  0.35
2005 Nixon DF, Deeks SG, Shacklett BL, Karlsson AC. Multidrug-resistant, dual-tropic HIV-1 and rapid progression. Lancet (London, England). 365: 1924-5. PMID 15936414 DOI: 10.1016/S0140-6736(05)66653-6  0.309
2005 Nixon DF, Aandahl EM, Michaëlsson J. CD4+CD25+ regulatory T cells in HIV infection. Microbes and Infection. 7: 1063-5. PMID 15893493 DOI: 10.1016/j.micinf.2005.03.026  0.343
2004 Schweighardt B, Roy AM, Meiklejohn DA, Grace EJ, Moretto WJ, Heymann JJ, Nixon DF. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1. Journal of Virology. 78: 9164-73. PMID 15308712 DOI: 10.1128/JVI.78.17.9164-9173.2004  0.323
2004 Aandahl EM, Quigley MF, Moretto WJ, Moll M, Gonzalez VD, Sönnerborg A, Lindbäck S, Hecht FM, Deeks SG, Rosenberg MG, Nixon DF, Sandberg JK. Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment. Blood. 104: 3672-8. PMID 15308569 DOI: 10.1182/blood-2004-07-2540  0.32
2004 Plana M, Garcia F, Oxenius A, Ortiz GM, Lopez A, Cruceta A, Mestre G, Fumero E, Fagard C, Sambeat MA, Segura F, Miró JM, Arnedo M, Lopalcos L, Pumarola T, ... ... Nixon DF, et al. Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3. Journal of Acquired Immune Deficiency Syndromes (1999). 36: 791-9. PMID 15213562 DOI: 10.1097/00126334-200407010-00005  0.34
2004 Shacklett BL, Cox CA, Quigley MF, Kreis C, Stollman NH, Jacobson MA, Andersson J, Sandberg JK, Nixon DF. Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection. Journal of Immunology (Baltimore, Md. : 1950). 173: 641-8. PMID 15210827 DOI: 10.4049/Jimmunol.173.1.641  0.427
2004 Shacklett BL, Cox CA, Wilkens DT, Karlsson RK, Nilsson A, Nixon DF, Price RW. Increased adhesion molecule and chemokine receptor expression on CD8 + T cells trafficking to cerebrospinal fluid in HIV-1 infection Journal of Infectious Diseases. 189: 2202-2212. PMID 15181567 DOI: 10.1086/421244  0.414
2004 Karlsson AC, Younger SR, Martin JN, Grossman Z, Sinclair E, Hunt PW, Hagos E, Nixon DF, Deeks SG. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. Aids (London, England). 18: 981-9. PMID 15096800 DOI: 10.1097/00002030-200404300-00005  0.422
2003 Karlsson AC, Martin JN, Younger SR, Bredt BM, Epling L, Ronquillo R, Varma A, Deeks SG, McCune JM, Nixon DF, Sinclair E. Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells Journal of Immunological Methods. 283: 141-153. PMID 14659906 DOI: 10.1016/j.jim.2003.09.001  0.339
2003 Alexander TH, Ortiz GM, Wellons MF, Allen A, Grace EJ, Schweighardt B, Brancato J, Sandberg JK, Furlan SN, Miralles GD, Nixon DF, Bartlett JA. Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (1999). 34: 475-81. PMID 14657757 DOI: 10.1097/00126334-200312150-00005  0.379
2003 Shacklett BL, Yang O, Hausner MA, Elliott J, Hultin L, Price C, Fuerst M, Matud J, Hultin P, Cox C, Ibarrondo J, Wong JT, Nixon DF, Anton PA, Jamieson BD. Optimization of methods to assess human mucosal T-cell responses to HIV infection. Journal of Immunological Methods. 279: 17-31. PMID 12969544 DOI: 10.1016/S0022-1759(03)00255-2  0.398
2003 Papasavvas E, Sandberg JK, Rutstein R, Moore EC, Mackiewicz A, Thiel B, Pistilli M, June RR, Jordan KA, Gross R, Maino VC, Nixon DF, Montaner LJ. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression. The Journal of Infectious Diseases. 188: 873-82. PMID 12964119 DOI: 10.1086/377645  0.379
2003 Karlsson AC, Deeks SG, Barbour JD, Heiken BD, Younger SR, Hoh R, Lane M, Sällberg M, Ortiz GM, Demarest JF, Liegler T, Grant RM, Martin JN, Nixon DF. Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene. Journal of Virology. 77: 6743-52. PMID 12767994 DOI: 10.1128/JVI.77.12.6743-6752.2003  0.388
2003 Shacklett BL, Cox CA, Sandberg JK, Stollman NH, Jacobson MA, Nixon DF. Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection. Journal of Virology. 77: 5621-31. PMID 12719554 DOI: 10.1128/Jvi.77.10.5621-5631.2003  0.403
2003 Sandberg JK, Fast NM, Jordan KA, Furlan SN, Barbour JD, Fennelly G, Dobroszycki J, Spiegel HM, Wiznia A, Rosenberg MG, Nixon DF. HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. Journal of Immunology (Baltimore, Md. : 1950). 170: 4403-10. PMID 12682278  0.387
2002 Shacklett BL, Ling B, Veazey RS, Luckay A, Moretto WJ, Wilkens DT, Hu J, Israel ZR, Nixon DF, Marx PA. Boosting of SIV-specific T cell responses in rhesus macaques that resist repeated intravaginal challenge with SIVmac251. Aids Research and Human Retroviruses. 18: 1081-8. PMID 12396459 DOI: 10.1089/08892220260235434  0.356
2002 Keir ME, Rosenberg MG, Sandberg JK, Jordan KA, Wiznia A, Nixon DF, Stoddart CA, McCune JM. Generation of CD3+CD8low thymocytes in the HIV type 1-infected thymus. Journal of Immunology (Baltimore, Md. : 1950). 169: 2788-96. PMID 12193754  0.371
2002 Shacklett BL, Means RE, Larsson M, Wilkens DT, Beadle TJ, Merritt MJ, Bhardwaj N, Palumbo PE, Skurnick JH, Louria DB, Nixon DF. Dendritic cell amplification of HIV type 1-specific CD8+ T cell responses in exposed, seronegative heterosexual women. Aids Research and Human Retroviruses. 18: 805-15. PMID 12167272 DOI: 10.1089/08892220260139558  0.456
2002 Sandberg JK, Fast NM, Palacios EH, Fennelly G, Dobroszycki J, Palumbo P, Wiznia A, Grant RM, Bhardwaj N, Rosenberg MG, Nixon DF. Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. Journal of Virology. 76: 7528-34. PMID 12097565 DOI: 10.1128/Jvi.76.15.7528-7534.2002  0.397
2002 Skurnick JH, Palumbo P, DeVico A, Shacklett BL, Valentine FT, Merges M, Kamin-Lewis R, Mestecky J, Denny T, Lewis GK, Lloyd J, Praschunus R, Baker A, Nixon DF, Stranford S, et al. Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. The Journal of Infectious Diseases. 185: 428-38. PMID 11865394 DOI: 10.1086/338830  0.414
2002 Larsson M, Wilkens DT, Fonteneau JF, Beadle TJ, Merritt MJ, Kost RG, Haslett PA, Cu-Uvin S, Bhardwaj N, Nixon DF, Shacklett BL. Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells. Aids (London, England). 16: 171-80. PMID 11807300 DOI: 10.1097/00002030-200201250-00005  0.373
2002 Ortiz GM, Hu J, Goldwitz JA, Chandwani R, Larsson M, Bhardwaj N, Bonhoeffer S, Ramratnam B, Zhang L, Markowitz MM, Nixon DF. Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection Journal of Virology. 76: 411-415. PMID 11739706 DOI: 10.1128/Jvi.76.1.411-415.2002  0.41
2000 Jin X, Ogg G, Bonhoeffer S, Safrit J, Vesanen M, Bauer D, Chen D, Cao Y, Demoitie M, Zhang L, Markowitz M, Nixon D, McMichael A, Ho DD. An Antigenic Threshold for Maintaining Human Immunodeficiency Virus Type 1-specific Cytotoxic T Lymphocytes Molecular Medicine. 6: 803-809. DOI: 10.1007/Bf03402195  0.415
1999 Larsson M, Jin X, Ramratnam B, Ogg GS, Engelmayer J, Demoitie MA, McMichael AJ, Cox WI, Steinman RM, Nixon D, Bhardwaj N. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. Aids (London, England). 13: 767-77. PMID 10357375 DOI: 10.1097/00002030-199905070-00005  0.495
1996 Allsopp CEM, Plebanski M, Gilbert S, Sinden RE, Harris S, Frankel G, Dougan G, Hioe C, Nixon D, Paoletti E, Layton G, Hill AVS. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. European Journal of Immunology. 26: 1951-1959. PMID 8765044 DOI: 10.1002/Eji.1830260841  0.339
1993 Gotch F, Nixon D, Gallimore A, McAdam S, McMichael A. Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV. Journal of Medical Primatology. 22: 119-123. DOI: 10.1111/J.1600-0684.1993.Tb00649.X  0.453
1991 Nixon D. Vaccines for HIV infected pregnant women Bmj. 303: 1061-1061. PMID 1954470 DOI: 10.1136/Bmj.303.6809.1061  0.381
1991 Nixon D. Zidovudine after occupational exposure to HIV. Bmj. 303: 250-251. PMID 1884077 DOI: 10.1136/Bmj.303.6796.250-C  0.411
Show low-probability matches.